Friday, March 28, 2025
spot_img

GOGL – Filing of 2024 Annual Report on Form 20-F

Golden Ocean Group Limited (NASDAQ and OSE: GOGL) (the “Company”) announces that its annual report on Form 20-F for the year ended December 31, 2024 (the “Annual Report”) has been filed with the U.S. Securities and Exchange Commission (the “Commission”). The Annual Report may be accessed through the Company’s website, www.goldenocean.bm, or in the link below. The Annual Report is also available on the website of the Commission, www.sec.gov.

Shareholders may also request a hard copy of the Annual Report, which includes the Company’s complete 2024 audited financial statements, by contacting the Investor Relations department.

        
Golden Ocean Group Limited
Hamilton, Bermuda
March 20, 2025

Contact Person:
Peder Simonsen: Interim Chief Executive Officer and Chief Financial Officer, Golden Ocean Management AS
+47 22 01 73 40

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

 

Attachments

  • GOGL – 2024 20F
  • GOGL – 2024 20F

Powered by SlickText.com

Hot this week

Intercont (Cayman) Limited Announces Pricing of Its Initial Public Offering

HONG KONG, March 27, 2025 (GLOBE NEWSWIRE)...

Yukon Metals Announces Upsize in Private Placement to C$10M

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR...

CORRECTING and REPLACING: Reed’s Reports Fourth Quarter and Full Year 2024 Results

NORWALK, Conn., March 27, 2025 (GLOBE NEWSWIRE)...

VitalHub Reports Fourth Quarter and Annual 2024 Results

Annual Recurring Revenue (ARR)⁽¹⁻²⁾ up 59% YoY to $71.1...

Fortuna files Form 40-F, Annual Report

VANCOUVER, British Columbia, March 27, 2025 (GLOBE...

Topics

Yukon Metals Announces Upsize in Private Placement to C$10M

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR...

VitalHub Reports Fourth Quarter and Annual 2024 Results

Annual Recurring Revenue (ARR)⁽¹⁻²⁾ up 59% YoY to $71.1...

Fortuna files Form 40-F, Annual Report

VANCOUVER, British Columbia, March 27, 2025 (GLOBE...

Acrivon Therapeutics Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results

Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational...
spot_img

Related Articles

Popular Categories

spot_img